Status:
UNKNOWN
Observational Cohort Study of Advanced Non-small Cell Lung Cancer (CAPTRA-LUNG)
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Advanced Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Investigators propose to establish and maintain a cohort of patients with advanced non-small cell lung cancer, and to assess the treatment pattern, host genetic, and clinical factors which influence t...
Eligibility Criteria
Inclusion
- Cohort I: diagnosis of advanced non-small cell lung cancer from 2012-2016;
- Cohort II: documented positive driver gene mutations; and diagnosis of advanced non-small cell lung cancer;
- Cohort III: diagnosis of advanced non-small cell lung cancer and in immune-therapy;
- Cohort IV: diagnosis of advanced non-small cell lung cancer, and with wild-type driver gene or unknown driver gene status;
- Cohort V: treated with anti-VEGF drug in first line, diagnosis of advanced non-squamous and non-small cell lung cancer in 6 months before recruit;
- Age\>18 years;
- Provision of written informed consent.
Exclusion
- not applicable
Key Trial Info
Start Date :
November 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03334864
Start Date
November 3 2022
End Date
December 1 2025
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730